Clinical Trial Update: A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating ASA404 alone and in combination with taxane-based chemotherapies in patients with advanced solid tumors. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ASA404 (vadimezan)
• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Solid Tumor Malignancies | Phase 1 | Status: TERMINATED